Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications-Reference-Cited by-同舟云学术

Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications

Published:2017-03 Issue:3 Volume:216 Page:259.e1-259.e6
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Siedhoff Matthew T.^ORCID,Doll Kemi M.,Clarke-Pearson Daniel L.,Rutstein Sarah E.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference27 articles.

1. Food and Drug Administration. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. Available at: http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm393576.htm. Accessed Sept. 25, 2016.

2. Impact of the 2014 Food and Drug Administration warnings against power morcellation;Lum;J Minim Invasive Gynecol,2016

3. Impact of the Food and Drug Administration safety communication on the use of power morcellator in daily clinical practice: an Italian survey;Mandato;J Minim Invasive Gynecol,2016

4. Association of the US Food and Drug Administration morcellation warning with rates of minimally invasive hysterectomy and myomectomy;Barron;Obstet Gynecol,2015

5. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation;Harris;Am J Obstet Gynecol,2016

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis and treatment of uterine sarcoma found incidentally after myomectomy;European Journal of Surgical Oncology;2024-11

2. Clinicopathological and survival analysis for patients with uterine sarcoma treated following surgery for presumed benign disease;BMC Cancer;2024-09-09

3. Case report: Magnetic resonance imaging findings of patients with diffuse uterine leiomyomatosis;Frontiers in Oncology;2024-07-03

4. Opportunities for change and levelling up: a trust wide retrospective analysis of 8 years of laparoscopic and abdominal myomectomy;Facts, Views and Vision in ObGyn;2024-06

5. Potential Markers to Differentiate Uterine Leiomyosarcomas from Leiomyomas;International Journal of Medical Sciences;2024